ClinicalTrials.gg
Drug

Desloratadine clinical trials

Also written SCH 034117, Aerius, Clarinex and SCH 34117.

studies test it
55
open now
6
in phase 3
17
first study started
2002

How each study uses desloratadine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the desloratadine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
21 Dec 2001 · CLARINEX · NDA 021165 (FDA, Drugs@FDA)
European Union
15 Jan 2001 · Azomyr · EMEA/H/C/000310 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Desloratadine
34
Desloratadine 5 mg
5
Desloratadine 5 mg (Clarinex)
3
Clarinex, SCH 34117
3
Clarinex; Aerius; SCH 34117; descarboethoxyloratadine
3

Brand

Aerius
4
Clarinex
3
Clarinex® 5 mg
2

Development codes

SCH 034117
5
SCH 34117
3

In one entry with another drug

Given together, or one or the other

Desloratadine + Prednisolone
3
Desloratadine and pseudoephedrine
2
Clarinex D-24
2

Studies by the year they started

54 studies that test it; most in 2013 (7); 1 more planned to start later

Studies that test desloratadine, by start year
YearStudies
20026
20036
20046
20056
20066
20072
20081
20092
20137
20141
20151
20181
20191
20201
20221
20231
20241
20264

By phase

A phase 1/2 study counts in both.

Phase 1
6
Phase 2
7
Phase 3
17
Phase 4
22
No phase
3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 39 · Other 16

Organon and Co (27) · Dr. Reddy's Laboratories Limited (6) · EMS (3) · Charite University, Berlin, Germany (2) · Horus University (2) · Chulalongkorn University (1) · Eurofarma Laboratorios S.A. (1) · Universitaire Ziekenhuizen KU Leuven (1)

Often tested with

Tested in the same studies.

Cetirizine (10) · Prednisolone (4) · Diphenhydramine (2) · Pseudoephedrine (2) · Cilostazol (1) · Dipyridamole (1) · Oxybutynin (1) · Aprepitant (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 4

Studies that test desloratadine.

Studies

Open first, then newest update. How each study uses desloratadine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 55

See all 55 studies that test desloratadine →

Given beside what is tested · 7 — desloratadine is usual care or a partner of the new treatment
As the comparator · 7 — what is tested is compared with desloratadine

Codes

What other systems call desloratadine · ClinicalTrials.gg INT004178

  • MeSH (NLM) C121345desloratadineConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) FVF865388RDESLORATADINEConfirmed FDA, NLM, Wikidata
  • RxNorm 275635Confirmed FDA, Wikidata
  • Wikidata Q418060desloratadineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C47474DesloratadineOne source FDA
  • DrugBank DB00967One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.